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TREATMENT OF ALLERGIC AND SOME OTHER DERMATOSES
WITH THEPHORIN
A PRELIMINARY REPORT
BEATRICE MAIlER KESTEN, M.D. AND CHARLES SHEARD, JR., M.D.*
Thephorin,' a hydrogenated phenyl-pyridine derivative, exhibits anti-histaminic and
anti-spasmodic actiYity in experimental animals. Experiments covering its action, toxicity
and anti-histaminic properties were sufficiently encouraging to warrant its use in derma-
toses in which histamine was thought to produce symptoms.
Thephorin was supplied in capsules containing 25 mg. and 50 mg. and in ampoules con-
taining 50 mg. in solution.
SERUM SICKNESS
Two patients with severe serum sickness following tetanns antitoxin received 50 mg.
of Thephorin at four hour intervals for a day. Within 12 hours the fever and itching had
subsided. 50 mg. was then given after meals for four days. After three and four days,
respectively, the patients were free of symptoms.
DEEMOGRAPMISM
Three patients with marked dermographism and itching have taken 50 mg. of Thephorin
after meals for from one to four months. It is still possible to produce wheals by stroking
the skin, but itching is absent.
URTICARIA
Due to cold: Three patients, who developed hives on exposure to cold, took 50 mg. of
Thephorin 30 minutes before exposure to the cold. The itching was absent and urticaria
was minimal. During the winter they have taken 50-150 ng. daily, depending on the
weather, with marked relief.
Due to food: Eight patients who developed urticaria after eating specific foods took
50 mg. after meals and 100 mg. at bedtime until free from attacks. All experienced relief
from itching. In five the attacks were shortened. Four patients repeated this dose for
two days before trying the food to which they were sensitive. All developed urticaria
but without itching. Three felt that the attacks were milder.
Of unknown ceuse: Ten patients with an initial attack and fifteen with chronic urticaria
took from 100—300 mg. daily for one week. In fifteen itching was minimal or absent within
a few hours after the ingestion of the drug. Eight with acute urticaria were symptom-free
within the week. Nine with recurrent attacks have continued the drug from one to seven
months, taking it daily or if hives appear. Attacks are shorter, less severe, and itching is
usually absent.
ALLERCIC ECZEMA AND OTHER DEEMATOSES
To test its anesthetic effect on uncontrolled itching, Thephorin (150—300 mg. daily for
1—2 weeks) was added to the treatment of 39 patients with the following diseases: Erythema
Multiforme (2); Papular Urticaria (3); Neurodermite [Lichen Chronicus Circumseriptus
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(Ed.)] (4); Pruritis Ani (8); Allergic Eczema2 (15); Psoriasis (4); and one patient with each
of the following: Flodgkin's Disease; Eosinophilic Disease of the Skin; Localized Amyloido-
sis.
Thephorin was remarkably effective in allaying itching in the first four diseases listed
and in the patient with amyloidosis. It also relieved itching in seven of the patients with
Allergic Eczema.
SIDE EFFECTS
The drug was discontinued in twenty-one patients because of unpleasant symptoms.
Tbese usually appeared within 48 hours and disnppeared shortly after discontinuing the
drug. In order of frequency they were: nausea, anorexia, headache, drowsiness, palpi-
tation, restlessness, depression, vomiting, indigestion, increase in itching and dizziness.
EFFECT OF THEPHORIN ON EXPEIII1EENTAL WHEAL5
The histernine wheel: A drop of 1:1,000 histamine phosphate was placed on the forearm
of two normal subjects and two with cold urticaria. These sites were then pricked. Within
5 minutes the usual histamine wheal with erythema and itching was present. The patients
then received 50 mg. of Thephorin subcutaneously. In 20 minutes the histamine test was
repeated. There was no diminution in the wheal formation but itching was absent in
three sites. These patients then took 125 mg. daily for one week and then were retested
with histamine. Wheals formed, but there was no itching.
The positive skin test: Three allergic patients developed wheals and itching at the sites
of intraeutaneous tests to egg, cod and wheat, respectively. These patients then took
250 mg. of Thephorin daily for one week and were again tested with these antigens. There
was no influence on the wheal formation but itching was absent in two patients.
J)ermographisn't: The skin of two patients with dermographism was stroked and the
interval between stroking and the formation of a linear wheal was timed. The patients
were given 50 mg. of Thephorin subcutaneously. In 20 minutes the skin was again stroked.
There was no change in svheal formation but itching was absent.
SUMMART
Thephorin was effective in thirty-three of forty-one patients with dermatoses charac-
terized by wheal formation.
It was a worthy adjuvant in allaying itching in twenty-two of thirty-nine patients with
intensely pruritie dermatoses.
Thephorin prevented itching in wheals produced experimentally.
Side effects, of sufficient intensity to discontinue the drug, occurred in one-fourth of the
patients.
2 Personal communication with the authors indicated that "Allergic Eczema" refers
to the dermatosis which is now generally referred to as "Atopic Dermatitis." Ed.
